SPOP and prostate cancer: However, mutation of SPOP, which is frequently observed in prostate cancer and other cancers, disrupted SPOP–substrate co-localization and phase separation, thus reducing ubiquitylation and proteasomal degradation of proto-oncogenic proteins (99).